ReviewOperative Orthopadie und Traumatologie2026
[Autologous fibular transplantation for reconstruction of segmental bone defects].
Review in Operative Orthopadie und Traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBiological reconstruction of extensive meta-/diaphyseal bone defects using autologous fibular graft. Aim is stable defect bridging with preservation of the limb and restoration of function. INDICATIONS: Intercalary bone defects caused by joint-preserving tumor resection of bone tumors, failed osteosyntheses with pseudarthrosis, chronic osteomyelitis after debridement, posttraumatic or congenital bone loss. Vascularized grafts are particularly indicated in cases of compromised soft tissue, previous radiotherapy, defects > 10-12 cm, or anticipated delayed healing. CONTRAINDICATIONS: Severe peripheral arterial occlusive disease (donor or recipient site); active infections. Relative contraindications for vascularized grafts include short, biologically active defects with intact perfusion. SURGICAL TECHNIQUE: Harvesting of the fibula as a vascularized or nonvascularized segment, adaptation to the defect, fixation using plates. In tumor resections possible combination with allografts or extracorporeally irradiated autografts (using Capanna technique)-especially in the lower leg to improve mechanical stability. Microsurgical vascular anastomoses are required for vascularized fibula. POSTOPERATIVE MANAGEMENT: Early mobilization under unloading conditions, regular radiographic monitoring, and gradual weight-bearing based on consolidation. Physiotherapy to prevent joint stiffness; clinical monitoring of the donor site.
resultsConsolidation rates of 85-95% under appropriate fixation and soft tissue coverage. Fibula grafts show high biological integration, potential for hypertrophy under load, and long-term load capacity. Typical complications include nonunion, graft fracture, infection, vascular complications, and donor-site morbidity.
Indexed as
Identifiers
41537834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.